Imagin Medical Announces Stock Option Grant
25 June 2019 - 6:45AM
Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart
Symbol: DPD2) (the “Company”) announced that, under its stock
option plan, it has granted incentive stock options to a consultant
of the Company to acquire an aggregate of 900,000 common shares at
a price of $0.10 per share, for a period of five years from the
date of grant.
About Imagin MedicalImagin
Medical is a surgical imaging company focused on establishing a new
standard of care in visualizing cancer during minimally invasive
surgeries. The Company believes its first product, the i/Blue™
Imaging System, will dramatically improve surgeons’ ability to
visualize cancerous cells by producing higher-quality images more
quickly compared with current methods. Based on advanced optics and
light sensors, the i/Blue Imaging System employs patented
ultrasensitive imaging technology and offers easy-to-use viewing
options for more accurate resection. The Company’s initial focus is
bladder cancer. Learn more at www.imaginmedical.com.
Forward-Looking
StatementsInformation set forth in this news release
contains forward-looking statements. These statements reflect
management’s current estimates, beliefs, intentions and
expectations; they are not guarantees of future performance. The
Company cautions that all forward-looking statements are inherently
uncertain, and that actual performance may be affected by a number
of material factors, many of which are beyond the Company’s
control. Accordingly, actual and future events, conditions and
results may differ materially from the estimates, beliefs,
intentions and expectations expressed or implied in the
forward-looking information. Specifically, there is no assurance
the Company’s imaging system will work in the manner expected.
Except as required under applicable securities legislation, the
Company undertakes no obligation to publicly update or revise
forward-looking information. The CSE has neither approved nor
disapproved the information contained herein and does not accept
responsibility for the adequacy or accuracy of this news
release.
Contacts:Stephen Kilmer, Investor
RelationsTelephone: 647-872-4849Email: stephen@kilmerlucas.com
Jim Hutchens, President & CEOTelephone: 833-246-2446Email:
jhutchens@imaginmedical.com
NR-2019-IME #35
Imi Medical Innovations (AMEX:IME)
Historical Stock Chart
From Nov 2024 to Dec 2024
Imi Medical Innovations (AMEX:IME)
Historical Stock Chart
From Dec 2023 to Dec 2024
Real-Time news about Imi International Medical Innovations (American Stock Exchange): 0 recent articles
More News Articles